3,4-Methylenedioxyphentermine
From Wikipedia, the free encyclopedia
(Redirected from MDPH)
 |
This article relies largely or entirely upon a single source. (August 2016) |
 |
|
| Names | |
|---|---|
| IUPAC name
1-(1,3-Benzodioxol-5-yl)-2-methylpropan-2-amine
|
|
| Other names
3,4-Methylenedioxyphentermine;
3,4-Methylenedioxy-alpha,alpha-dimethyl-1-ethane |
|
| Identifiers | |
39235-63-7  |
|
| 3D model (Jmol) | Interactive image |
| ChemSpider | 15204207  |
|
|
|
|
| Properties | |
| C11H15NO2 | |
| Molar mass | 193.25 g·mol−1 |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
 verify (what is ?) |
|
| Infobox references | |
3,4-Methylenedioxyphentermine (MDPH) is a lesser-known psychedelic drug. MDPH was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the dosage range is listed as 160–240 mg, and the duration as 3–5 hours.[1] MDPH's effects are very similar to those of MDA: they both are smooth and "stoning," and do not cause any visuals. They also alter dreams and dream patterns. Shulgin describes MDPH as a promoter; it promotes the effects of other drugs, similarly to 2C-D. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDPH.
See also[edit]
References[edit]
 |
This Hallucinogen-related article is a stub. You can help Wikipedia by expanding it. |
